首页> Leukemia & lymphoma> Relative efficacy of treatment options in transplant-ineligible newly diagnosed multiple myeloma: results from a systematic literature review and network meta-analysis.

Relative efficacy of treatment options in transplant-ineligible newly diagnosed multiple myeloma: results from a systematic literature review and network meta-analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Karthik,Ramasamy

第一单位： National Institute for Health Research, Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

作者： Karthik,Ramasamy ^[1] ; Sujith,Dhanasiri ^[2] ; Howard,Thom ^[3] ; Vanessa,Buchanan ^[4] ; Suzanne,Robinson ^[2] ; Vijay K,D'Souza ^[4] ; Katja,Weisel ^[5]

作者单位： National Institute for Health Research, Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. ^[1] Celgene International, Boudry, Switzerland. ^[2] Bristol Medical School, University of Bristol, Bristol, UK. ^[3] Cogentia Healthcare Consulting Ltd, Cambridge, UK. ^[4] Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[5]

关键词 Multiple myeloma network meta-analysis systematic literature review treatment-naive

医学主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);人类(Humans);美法仑(Melphalan);多发性骨髓瘤(Multiple Myeloma);沙立度胺(Thalidomide);治疗结果(Treatment Outcome)

DOI 10.1080/10428194.2019.1683736

PMID 31709875

发布时间 2025-05-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交